Tracked shipping to South Africa with premium packaging for just R199 

Ship to
South Africa
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Clinical Use of Antibodies: Tumours, Infection, Infarction, Rejection and in the Diagnosis of AIDS
Type
Physical Book
Publisher
Author
Language
English
Pages
185
Format
Paperback
Dimensions
23.4 x 15.6 x 1.1 cm
Weight
0.29 kg.
ISBN13
9789401055550
Categories

Clinical Use of Antibodies: Tumours, Infection, Infarction, Rejection and in the Diagnosis of AIDS

Baum, Richard P. ; Cox, P. H. ; Hör, Gustav (Author) · Springer · Paperback

Clinical Use of Antibodies: Tumours, Infection, Infarction, Rejection and in the Diagnosis of AIDS - Baum, Richard P. ; Cox, P. H. ; Hör, Gustav

Cheaper New Book Imported to South Africa
Delivery: 21 Jul - 14 Aug Shipping: 12 to 14 business days.
R 1,880
Faster New Book Imported to South Africa
Delivery: 09 Jul - 03 Aug Shipping: 4 to 5 business days.
R 2,299
R 1,880

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Clinical Use of Antibodies: Tumours, Infection, Infarction, Rejection and in the Diagnosis of AIDS"

It was at Frankfurt/Mainin 1899 that Paul Ehrlich first expounded his famous "site-chain theory" -which described the basic immunological principal of antibody-antigen interactio- on the occasion of the opening of the Institute for Experimental Therapeutics (which was later named after him). Nearly 100 years have passed since, and in retrospect it can be said that the "Ehrlich Era" (first steps in immunology "Magic Bullet" concept) and the "Behring Era" (detection of antibodies and serum therapy) formed the essential basis in the development of immunology. Niels K. Jerne, the former director of the Paul Ehrlich Institute in Frankfurt/Main received, together with Georges Kohler and Cesar Milstein, the Nobel Prize in Medicine 1984. These late successors of Ehrlich and Behring first described the hybridoma technology (in 1975) which enabled one of the most important and revolutionary technological innovations in the field of immunology -the production of monoclonal antibodies. It happens that, the time of the publication of this book, just a decade has passed since the first use of radiolabelled monoclonal antibodies in man (by the Lausanne Group). Over these 10 years a tremendous progress has taken place in the field of immunoscintigraphy: A large panel of highly specific monoclonal antibodies against tumour-associated antigens as well as normal cell compounds have been developed. Enormous progress has been made in the field of radiolabelling -from iodine-131 to technetium-99mor even positron-emittingradionuclides, e. g. iodine-124.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews